Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
bone repair
Biotech
Lack of early win for Ultragenyx’s bone disorder med dents stock
Analysts are keeping faith in Ultragenyx’s brittle bone disease medicine despite the monoclonal antibody failing to score an early outright trial win.
James Waldron
Jul 10, 2025 8:04am
Ultragenyx, Mereo's bone disease med cuts fractures by 67%
Oct 16, 2023 12:39pm
Bone Bolt system for complex fractures earns FDA nod
Jul 21, 2023 12:57pm
Bone breaks from original cell therapy plan, switching endpoint
Jul 15, 2022 8:25am
'Sonic the Hedgehog' gene could trigger bone injury repair
May 18, 2022 3:22pm
FDA approves Orthofix's ultrasonic bone fracture healing system
May 4, 2022 10:56am
